Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01615367 · ClinicalTrials.gov registry record · Phase 1
Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT01615367: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT01615367 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01615367, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in bipolar disorder, yet no empirically validated psychosocial interventions to manage risk factors for CVD in BD have been developed. The purpose of this study is to develop and test the feasibility of an integrated treatment to decrease CVD risk factors, while exploring whether the intervention improves overall functioning and mood symptoms. The designed treatment integrates theories on Nutrition strategies, Exercise interventions, and Wellness Treatment (NEW Tx) to address risk factors for CVD that co-occur with bipolar disorder. NEW Tx includes novel intervention strategies in each of these three modules, as well as modified and tailored empirically-supported strategies for bipolar disorder. The primary hypotheses are that NEW Tx will be feasible to deliver, acceptable to this population, and associated with improvements in CVD risk factors (i.e., waist circumference). Exploratory analyses will examine predictors of treatment response and the effect of NEW Tx on mood symptoms and overall functioning.
Interventions
- OTHER Nutrition, Exercise, and Wellness (NEW) psychotherapy
- DRUG Typically consists of at least one FDA-approved mood stabilizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2012-05-21 |
| Est. Completion | 2017-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01615367
The ClinicalTrials.gov registry entry for NCT01615367 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nutrition, Exercise, and Wellness (NEW) psychotherapy is the first listed.
NCT01615367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01615367 about?
NCT01615367 is a clinical study titled "Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder". Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in bipolar disorder, yet no empirically validated psychosocial interventions to manage risk factors for CVD in BD have been developed. The purpose of this study is to develop and test the feasibility of an integrated treatm...
What is the current status of trial NCT01615367?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2012-05-21. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT01615367?
The interventions under investigation include: Nutrition, Exercise, and Wellness (NEW) psychotherapy (OTHER), Typically consists of at least one FDA-approved mood stabilizer (DRUG).
Who is sponsoring clinical trial NCT01615367?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.